Facebook Linkedin Twitter
Inside Precision Medicine Adding Ruxolitinib to TKI Treatments Enhances Molecular Response in Chronic Myeloid Leukemia

Leukemia

TKI Acalabrutinib molecular structure isolated on white
News & Features

Adding Ruxolitinib to TKI Treatments Enhances Molecular Response in Chronic Myeloid Leukemia

0
prostate cancer cells, SEM. CRPC
News & Features

New Prostate Cancer Treatment Shows Promise in Preclinical Studies

0
Cancer Gene
News & Features

New DNA-Targeting Screening Technique for Cancer Therapies

0
Acute lymphoblastic leukaemia, illustration
News & Features

Non-Coding DNA Found to Be Major Driver of T-Lineage Acute Lymphoblastic Leukemia

0
Blood Testing
News & Features

Minimal Disease, Maximum Benefit

Chris Anderson
0
Acute myeloid leukemia (AML)
News & Features

New Therapeutic Target Found for Acute Myeloid Leukemia

0
HIV viruses, illustration
News & Features

Second HIV Patient “Cured” with Stem Cell Transplant at Charité, Using Slightly Different Genetic Recipe

0
Cancer cell surrounded by therapeutic antibodies and cytokines among normal cells
News & Features

Vertex and Orum Launch $945M+ Collaboration to Replace Chemotherapy with DAC

0
Acute myeloid leukemia (AML)
News & Features

Compound Engineered to Combat Drug-Resistant Acute Myeloid Leukemia

0
Immunoglobulin G—IgG—antibody molecule
News & Features

Frequent Immunoglobulin Testing Reduces Infections in CLL and NHL Patients

0
123...18Page 2 of 18

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine